2) Werning G, et al: Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood 107: 4274-4281, 2006.
3) Lacout C, et al: JAK2V617F expression in murine hamatopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis. Blood 108: 1652-1660, 2006.
4) Bumm TGP, et al: Characterization of murine JAK2V617F-positive myeloproliferative disease. Cancer Res 66: 11156-11165, 2006.
5) Zaleskas VM, et al: Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F. PLoS ONE 1: 1-11, 2006.